These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15006494)

  • 41. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.
    Petkova-Kirova P; Rakovska A; Zaekova G; Ballini C; Corte LD; Radomirov R; Vágvölgyi A
    Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of the cholinergic system in the pathology and treatment of schizophrenia.
    Scarr E; Dean B
    Expert Rev Neurother; 2009 Jan; 9(1):73-86. PubMed ID: 19102670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation.
    Brun P; Mastrotto C; Beggiao E; Stefani A; Barzon L; Sturniolo GC; Palù G; Castagliuolo I
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G621-9. PubMed ID: 15764810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathophysiology of antipsychotic drug-induced movement disorders.
    Casey DE
    J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurotensin: dual roles in psychostimulant and antipsychotic drug responses.
    Dobner PR; Deutch AY; Fadel J
    Life Sci; 2003 Jun; 73(6):801-11. PubMed ID: 12801600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of neuropeptide systems in schizophrenia: human studies.
    Cáceda R; Kinkead B; Nemeroff CB
    Int Rev Neurobiol; 2007; 78():327-76. PubMed ID: 17349866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytokines in schizophrenia and the effects of antipsychotic drugs.
    Drzyzga L; Obuchowicz E; Marcinowska A; Herman ZS
    Brain Behav Immun; 2006 Nov; 20(6):532-45. PubMed ID: 16580814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurotensin receptor binding and neurotensin-induced growth signaling in prostate cancer PC3 cells are sensitive to metabolic stress.
    Carraway RE; Hassan S
    Regul Pept; 2007 Jun; 141(1-3):140-53. PubMed ID: 17289170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Typical and atypical antipsychotic drugs target dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa and neurotensin-containing neurons, but not GABAergic interneurons in the shell of nucleus accumbens of ventral striatum.
    Ma J; Ye N; Cohen BM
    Neuroscience; 2006 Sep; 141(3):1469-80. PubMed ID: 16781818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Time-dependent cognitive deficits associated with first and second generation antipsychotics: cholinergic dysregulation as a potential mechanism.
    Terry AV; Mahadik SP
    J Pharmacol Exp Ther; 2007 Mar; 320(3):961-8. PubMed ID: 16966470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurotensin analogs indications for use as potential antipsychotic compounds.
    McMahon BM; Boules M; Warrington L; Richelson E
    Life Sci; 2002 Jan; 70(10):1101-19. PubMed ID: 11848295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurotensin receptors as modulators of glutamatergic transmission.
    Ferraro L; Tomasini MC; Mazza R; Fuxe K; Fournier J; Tanganelli S; Antonelli T
    Brain Res Rev; 2008 Aug; 58(2):365-73. PubMed ID: 18096238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antipsychotic drug action: targets for drug discovery with neurochemical imaging.
    Stone JM; Pilowsky LS
    Expert Rev Neurother; 2006 Jan; 6(1):57-64. PubMed ID: 16466312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Internalization-dependent regulation of HT29 cell proliferation by neurotensin.
    Navarro V; Martin S; Mazella J
    Peptides; 2006 Oct; 27(10):2502-7. PubMed ID: 16870305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endogenous neurotensin facilitates visceral nociception and is required for stress-induced antinociception in mice and rats.
    Gui X; Carraway RE; Dobner PR
    Neuroscience; 2004; 126(4):1023-32. PubMed ID: 15207335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurotensin modulation of spontaneous EPSCs in the nucleus accumbens of Lewis and Fischer 344 rats.
    Yang SW; Rompré PP; Warren RA
    Peptides; 2008 Sep; 29(9):1616-9. PubMed ID: 18556091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurotensin protects pancreatic beta cells from apoptosis.
    Coppola T; Béraud-Dufour S; Antoine A; Vincent JP; Mazella J
    Int J Biochem Cell Biol; 2008; 40(10):2296-302. PubMed ID: 18456542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development.
    Marek GJ
    Int Rev Neurobiol; 2007; 78():165-92. PubMed ID: 17349861
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effects of clozapine versus other antipsychotics on clinical outcome and dopamine release in the brain.
    Advokat C
    Essent Psychopharmacol; 2005; 6(2):73-90. PubMed ID: 15765792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.